Showing 1 - 3 results of 3 for search 'Michael R Collier', query time: 0.02s
Refine Results
-
1
Identification of cutaneous immune-related adverse events by International Classification of Diseases codes and medication administration by Wenxin Chen, BS, Guihong Wan, PhD, Nga Nguyen, MD, Bonnie Leung, BS, Jun Wen, PhD, Michael R. Collier, BS, Shawn G. Kwatra, MD, Yevgeniy R. Semenov, MD, MA
Published 2022-12-01
Article -
2
554 Clinical outcomes of patients treated with immune checkpoint inhibitor therapy for early-stage melanoma recurrence: a retrospective cohort study by Nga Nguyen, Shawn Kwatra, Yevgeniy R Semenov, Kimberly Tang, Guihong Wan, Boshen Yan, Bonnie W Leung, Ahmad Rajesh, Hannah Rashdan, Jordan Phillips, Michael R Collier, Min Seok Choi, Nora A Alexander, Ruple Jairath, Mia S DeSimone
Published 2023-11-01Article -
3
Prediction of early-stage melanoma recurrence using clinical and histopathologic features by Guihong Wan, Nga Nguyen, Feng Liu, Mia S. DeSimone, Bonnie W. Leung, Ahmad Rajeh, Michael R. Collier, Min Seok Choi, Munachimso Amadife, Kimberly Tang, Shijia Zhang, Jordan S. Phillipps, Ruple Jairath, Nora A. Alexander, Yining Hua, Meng Jiao, Wenxin Chen, Diane Ho, Stacey Duey, István Balázs Németh, Gyorgy Marko-Varga, Jeovanis Gil Valdés, David Liu, Genevieve M. Boland, Alexander Gusev, Peter K. Sorger, Kun-Hsing Yu, Yevgeniy R. Semenov
Published 2022-10-01
Article